» Articles » PMID: 26286633

A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of C-MYC G-quadruplex and Down-regulates C-MYC Transcription in Human Cancer Cells

Overview
Journal Sci Rep
Specialty Science
Date 2015 Aug 20
PMID 26286633
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The c-MYC proto-oncogene is a regulator of fundamental cellular processes such as cell cycle progression and apoptosis. The development of novel c-MYC inhibitors that can act by targeting the c-MYC DNA G-quadruplex at the level of transcription would provide potential insight into structure-based design of small molecules and lead to a promising arena for cancer therapy. Herein we report our finding that two simple bis-triazolylcarbazole derivatives can inhibit c-MYC transcription, possibly by stabilizing the c-MYC G-quadruplex. These compounds are prepared using a facile and modular approach based on Cu(I) catalysed azide and alkyne cycloaddition. A carbazole ligand with carboxamide side chains is found to be microenvironment-sensitive and highly selective for "turn-on" detection of c-MYC quadruplex over duplex DNA. This fluorescent probe is applicable to visualize the cellular nucleus in living cells. Interestingly, the ligand binds to c-MYC in an asymmetric fashion and selects the minor-populated conformer via conformational selection.

Citing Articles

Selective Recognition of G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains.

Fatma K, Thumpati P, Panda D, Velayutham R, Dash J ACS Med Chem Lett. 2024; 15(3):388-395.

PMID: 38505840 PMC: 10945540. DOI: 10.1021/acsmedchemlett.3c00537.


Molecular Insights into the Specific Targeting of G-Quadruplex by Thiazole Peptides.

Cao S, Su Q, Chen Y, Wang M, Xu Y, Wang L Int J Mol Sci. 2024; 25(1).

PMID: 38203794 PMC: 10778990. DOI: 10.3390/ijms25010623.


Synthesis and Biological Evaluation of Benzo [4,5]- and Naphtho[2',1':4,5]imidazo[1,2-c]pyrimidinone Derivatives.

Kamzeeva P, Dagaev N, Lizunova S, Khodarovich Y, Sogomonyan A, Kolchanova A Biomolecules. 2023; 13(11).

PMID: 38002351 PMC: 10669118. DOI: 10.3390/biom13111669.


Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer.

Long W, Zheng B, Li Y, Huang X, Lin D, Chen C Nucleic Acids Res. 2022; 50(4):1829-1848.

PMID: 35166828 PMC: 8887543. DOI: 10.1093/nar/gkac090.


Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox.

Kretzmann J, Irving K, Smith N, Evans C NAR Cancer. 2022; 3(4):zcab048.

PMID: 34988459 PMC: 8693572. DOI: 10.1093/narcan/zcab048.


References
1.
Jin R, Gaffney B, Wang C, Jones R, Breslauer K . Thermodynamics and structure of a DNA tetraplex: a spectroscopic and calorimetric study of the tetramolecular complexes of d(TG3T) and d(TG3T2G3T). Proc Natl Acad Sci U S A. 1992; 89(18):8832-6. PMC: 50015. DOI: 10.1073/pnas.89.18.8832. View

2.
Balagurumoorthy P, Brahmachari S . Structure and stability of human telomeric sequence. J Biol Chem. 1994; 269(34):21858-69. View

3.
Steiner P, Philipp A, Lukas J, Pagano M, Mittnacht S, Bartek J . Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J. 1995; 14(19):4814-26. PMC: 394579. DOI: 10.1002/j.1460-2075.1995.tb00163.x. View

4.
Dang C . c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1998; 19(1):1-11. PMC: 83860. DOI: 10.1128/MCB.19.1.1. View

5.
Wu K, Grandori C, Amacker M, POLACK A, Lingner J, Dalla-Favera R . Direct activation of TERT transcription by c-MYC. Nat Genet. 1999; 21(2):220-4. DOI: 10.1038/6010. View